JP2023507188A5 - - Google Patents
Info
- Publication number
- JP2023507188A5 JP2023507188A5 JP2022537467A JP2022537467A JP2023507188A5 JP 2023507188 A5 JP2023507188 A5 JP 2023507188A5 JP 2022537467 A JP2022537467 A JP 2022537467A JP 2022537467 A JP2022537467 A JP 2022537467A JP 2023507188 A5 JP2023507188 A5 JP 2023507188A5
- Authority
- JP
- Japan
- Prior art keywords
- pyrazolo
- pyrimidine
- chlorophenyl
- methyl
- piperidine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1918815.0A GB201918815D0 (en) | 2019-12-19 | 2019-12-19 | Treatment of cancer |
| GB1918815.0 | 2019-12-19 | ||
| PCT/GB2020/053272 WO2021123798A1 (en) | 2019-12-19 | 2020-12-18 | 1h-pyrazolo[3,4-d]pyrimidine compounds useful for the treatment of platinum-resistant cancer |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023507188A JP2023507188A (ja) | 2023-02-21 |
| JP2023507188A5 true JP2023507188A5 (cg-RX-API-DMAC7.html) | 2023-12-25 |
| JP7740804B2 JP7740804B2 (ja) | 2025-09-17 |
Family
ID=69322944
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022537467A Active JP7740804B2 (ja) | 2019-12-19 | 2020-12-18 | 白金耐性がんの治療に有用な1h-ピラゾロ[3,4-d]ピリミジン化合物 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20230064189A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4077329A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7740804B2 (cg-RX-API-DMAC7.html) |
| GB (1) | GB201918815D0 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2021123798A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024255830A1 (zh) * | 2023-06-14 | 2024-12-19 | 南京正大天晴制药有限公司 | Akt抑制剂在制备预防或治疗卵巢癌药物中的用途 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2005322085B2 (en) * | 2004-12-28 | 2012-07-19 | Exelixis, Inc. | [1H-pyrazolo[3, 4-d]pyrimidin-4-yl]-piperidine or -piperazine compounds as serine-threonine kinase modulators (p70S6K, Atk1 and Atk2) for the treatment of immunological, inflammatory and proliferative diseases |
| EP2037931A2 (en) * | 2006-04-25 | 2009-03-25 | Astex Therapeutics Limited | Pharmaceutical combinations of pk inhibitors and other active agents |
| CN104876921A (zh) * | 2008-01-09 | 2015-09-02 | 阵列生物制药公司 | 作为AKT蛋白激酶抑制剂的5H-环戊二烯并[d]嘧啶 |
| CA2743242A1 (en) * | 2008-11-11 | 2010-05-20 | Eli Lilly And Company | P70 s6 kinase inhibitor and mtor inhibitor combination therapy |
-
2019
- 2019-12-19 GB GBGB1918815.0A patent/GB201918815D0/en not_active Ceased
-
2020
- 2020-12-18 WO PCT/GB2020/053272 patent/WO2021123798A1/en not_active Ceased
- 2020-12-18 EP EP20838201.0A patent/EP4077329A1/en active Pending
- 2020-12-18 US US17/786,355 patent/US20230064189A1/en active Pending
- 2020-12-18 JP JP2022537467A patent/JP7740804B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2009148673A (ru) | Производные пиразинона и их применение для лечения легочных заболеваний | |
| TWI620736B (zh) | 使用選擇性bcl-2抑制劑之治療方法 | |
| JP6363616B2 (ja) | オートタキシン阻害剤 | |
| JP2021532124A5 (cg-RX-API-DMAC7.html) | ||
| JP2021512143A5 (cg-RX-API-DMAC7.html) | ||
| CN107635975B (zh) | Dgat2抑制剂 | |
| CA2601508A1 (en) | Cyclopropanecarboxamide derivatives | |
| JP2013530179A (ja) | 呼吸器合胞体ウイルス(rsv)感染の処置に使用するためのウレイド−ピラゾール誘導体 | |
| JP2016506964A5 (ja) | ナトリウムチャネルの調節剤としてのキノリンおよびキノキサリンアミド | |
| ES2762193T3 (es) | Agonistas de proteína tirosina fosfatasa 1 que contiene dominio de homología Src-2 y métodos de tratamiento usando la misma | |
| RU2019136279A (ru) | C5 -Анилинохиназолиновые соединения и их использование в лечении рака | |
| EA020641B1 (ru) | Производные n-(1-фенил-3-алкилпиразол-5-ил)-n'-арилмочевины | |
| JP2015516434A5 (cg-RX-API-DMAC7.html) | ||
| JP2017502033A5 (cg-RX-API-DMAC7.html) | ||
| JP2009523812A5 (cg-RX-API-DMAC7.html) | ||
| JP2017509694A5 (cg-RX-API-DMAC7.html) | ||
| JP2016520515A5 (cg-RX-API-DMAC7.html) | ||
| RU2009118254A (ru) | Фенилацетамиды в качестве ингибиторов протеинкиназ | |
| RU2007146798A (ru) | ПРОИЗВОДНЫЕ 4-(2-АМИНО-1-ГИДРОКСИЭТИЛ)ФЕНОЛА КАК АГОНИСТЫ β2 АДРЕНЕРГИЧЕСКОГО РЕЦЕПТОРА | |
| RU2006126974A (ru) | Амидное производное и лекарственное средство | |
| JP2008110984A5 (cg-RX-API-DMAC7.html) | ||
| US9409895B2 (en) | Autotaxin inhibitors | |
| CA2660529A1 (en) | Benzimidazole derivatives useful in treatment of vallinoid receptor trpv1 related disorders | |
| JP2021523108A5 (cg-RX-API-DMAC7.html) | ||
| JP2020520957A5 (cg-RX-API-DMAC7.html) |